Heart Health Wins: Postmenopausal Women Outlive the Risks

The American Heart Association’s Life’s Essential 8 (LE8) and Life’s Crucial 9 (LC9) represent widely recognized benchmarks for evaluating overall cardiovascular well-being. A recent investigation has documented an inverse correlation between these metrics and both all-cause and cardiovascular-related mortality rates in postmenopausal women. It was observed that adiposity and systemic inflammation mechanisms partially accounted for these observed associations through statistical mediation. The findings from this research have been disseminated online today in the esteemed journal Menopause, the official publication of The Menopause Society.

Cardiovascular ailments continue to be the principal determinant of morbidity and mortality among women globally. This risk escalates significantly post-menopause owing to hormonal fluctuations, metabolic shifts, and the natural process of vascular aging. Consequently, a thorough assessment of cardiovascular health is imperative for pinpointing at-risk demographics and formulating effective preventative strategies tailored for postmenopausal individuals.

While elevated LE8 and LC9 scores have previously been linked to diminished risks of cardiovascular incidents and mortality, the fundamental mechanisms underlying these connections have not been fully elucidated. Postmenopausal women experience considerable transformations in their body composition and fat distribution patterns, particularly accumulating adipose tissue around the abdominal region, which exacerbates cardiometabolic risk. Furthermore, within this demographic, increased adiposity is often accompanied by a higher prevalence of inflammatory markers and metabolic disarray.

It was against this backdrop that the current study, encompassing over 7,800 postmenopausal women (among whom 1,313 experienced mortality during the follow-up period), was undertaken. The primary objectives were to investigate the relationships between LE8 and LC9 scores and the incidence of all-cause and cardiovascular mortality, and to ascertain whether adiposity-associated and inflammation-related factors statistically mediate these linkages. The study’s conclusions indicate a significant nexus: superior LC9 and LE8 scores were associated with reduced probabilities of succumbing to all-cause and cardiovascular mortality in postmenopausal women. Furthermore, the study confirmed that indicators related to adiposity and inflammation played a partial mediating role in these associations. These outcomes emphatically highlight the significance of a holistic approach to cardiovascular health assessment and underscore the advantages of maintaining favorable cardiometabolic profiles.

The research findings are detailed in the article titled “Mediation analysis of adiposity and inflammation in the associations of Life’s Crucial 9 and Life’s Essential 8 with mortality among postmenopausal women.”

We are already cognizant of the critical role lifestyle determinants such as dietary habits, physical activity, sleep patterns, and avoidance of smoking play in maintaining cardiac health. However, the results of this study powerfully accentuate the substantial impact these factors can exert. For women navigating the postmenopausal phase, achieving better overall cardiometabolic health profiles translates to a greater likelihood of longevity, indicating that a considerable portion of factors influencing our health span are indeed within our sphere of influence.

Dr. Stephanie Faubion, medical director for The Menopause Society